Source: PHARMIWEB

Alios Biopharma: New Data Published in the New England Journal of Medicine Shows Potential of Compound to Fight RSV Infection in Adults and Children

New Data Published in the New England Journal of Medicine Shows Potential of Compound to Fight RSV Infection in Adults and ChildrenAlios BioPharma, Inc., part of the Janssen Pharmaceutical Companies

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Lawrence Blatt's photo - Founder & CEO of Alios Biopharma

Founder & CEO

Lawrence Blatt

CEO Approval Rating

69/100

Read more